Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Haselmeier, Common Sensing Enter Agreement | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Haselmeier, Common Sensing Enter Agreement

To develop smart connected monitoring and support solutions for users of injectable medicines

By: Betsy Louda

, Contract Pharma

Haselmeier, a Swiss-based developer and manufacturer of innovative self-injection devices, and Common Sensing, a Cambridge-based smart injector monitoring and support solutions company, announced a partnership agreement to develop smart connected monitoring and support solutions for users of injectable medicines. 

Worldwide, over 16 billion injections of medicine are administered every year. Smart connected monitoring solutions for users of injectables is aimed helping them to properly administer those medicines to improve efficacy and quality of therapies.

Haselmeier’s drug delivery injection systems for self-administration will be combined with Common Sensing’s Gocap injector monitoring technology, creating a first-of-its-kind, next generation, smart disposable injector pen platform, to be available in 2019. This platform will be sold by Haselmeier and is expected to drive significant interest from new and existing Haselmeier injector customers. The combined injector pen-Gocap platform will record the time and amount of every injector dose, along with other information like storage temperature.

“Haselmeier is excited about the collaboration with Common Sensing. Both companies have recognized how complementary their technologies were and how much this partnership will provide value for both Companies and patients. The joint relationship we have built will enable Haselmeier and Common Sensing to rapidly bring a unique connected pen solution on the market,” said Paul Jansen, Haselmeier senior advisor and board member.

“This partnership is a fantastic, market shaping opportunity to merge the leading edge, Haselmeier D-Flex injector with our Gocap connected health technology in a scalable, commercial platform,” said Kevin Schmid, Common Sensing chief operating officer.

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics